New appointment at Greenleaf Health
This article was originally published in Scrip
Executive Summary
Former US FDA commissioner Dr Andrew von Eschenbach has joined the regulatory consulting firm Greenleaf Health as a senior advisor. Dr von Eschenbach, a urologic oncologist and former director of the National Cancer Institute, left the FDA on January 20th. At Greenleaf he will be reunited with Patrick Ronan, the firm's founder and president, who served as Dr von Eschenbach's chief of staff at the FDA in 2005 and 2006. Mr Ronan was vice-president of regulatory policy and external affairs at Novartis before starting his own consulting firm last year.